Skip to main content
C-RAD logo

C-RAD — Investor Relations & Filings

Ticker · CRAD ISIN · SE0002016352 LEI · 549300SPXLHF15W2CU25 ST Manufacturing
Open in API
Filings indexed 535 across all filing types
Latest filing 2021-03-02 Major Shareholding Noti…
Country SE Sweden
Listing ST CRAD

About C-RAD

https://c-rad.com/

C-RAD is a medical technology company that develops and supplies solutions for advanced radiation therapy. The company's core offering is its Surface Guided Radiation Therapy (SGRT) technology, which provides high-precision patient positioning, real-time intra-fractional motion management, and respiratory gating. These systems are designed to increase treatment accuracy, enhance patient safety, and improve workflow efficiency in radiation oncology clinics. C-RAD's product portfolio also includes solutions for tumor localization and workflow automation, aiming to help clinicians deliver effective radiotherapy treatments, improve clinical outcomes, and enhance the quality of life for cancer patients.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding and voting rights for a specific instrument (Aktier) held by Avanza Bank Holding AB for its pension subsidiary. It explicitly lists the 'Before the transaction' and 'After the transaction' holdings, including the number of shares and resulting percentage (5.03%). This structure is characteristic of mandatory regulatory filings reporting insider or major shareholder transactions. The closest matching category among the provided definitions is 'Major Shareholding Notification' (MRQ), which covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. Although it is a direct report of the transaction, not an announcement of a report, MRQ fits the content better than DIRS (Director's Dealing) as it pertains to a major shareholder/entity, not just a director's personal trade, and it is not a general regulatory filing (RNS) because a more specific category exists.
2021-03-02 English
Earnings Release 2020
Earnings Release Classification · 1% confidence The document is titled "C-RAD AB BOKSLUTSKOMMUNIKÉ" (Year-End Report Communication) and explicitly details financial results for the quarter (October-December 2020) and the full year (January-December 2020). It contains key financial metrics like orderingång (order intake), intäkter (revenues), rörelseresultat (operating result), and result after tax, along with a CEO commentary and detailed financial tables. This structure is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR), but since it covers the full year and uses the term 'Bokslutskommuniké' (Year-End Communication), it functions as the primary announcement of the annual results. Given the options, 'ER' (Earnings Release) is the closest fit for a period-end financial summary announcement, even though it covers the full year, as it is a communication summarizing the period's performance rather than the full, audited 10-K document itself. The length (over 55k characters) suggests it is more comprehensive than a typical brief ER, but it lacks the formal structure of a 10-K. However, the content is a direct release of period results, making ER the most appropriate classification among the choices provided for a results announcement. FY 2020
2021-01-28 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 1% confidence The document is a 'Year-End Report' for C-RAD AB covering the period January-December 2020. It contains comprehensive financial statements, including order intake, revenue, operating profit, net results, and detailed management commentary on financial development, cash flow, and operational expenses. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year (or in this case, a year-end summary that functions as a comprehensive financial report), it is classified as an Interim/Quarterly Report (IR). It is not an RPA because it contains the actual financial data, not just an announcement of the report. FY 2020
2021-01-28 English
C-RAD receives order for proton cancer treatment centers in the US
Regulatory Filings Classification · 1% confidence The document is a press release dated 2020-12-28 announcing that C-RAD has received an order for its surface tracking technology for three proton cancer treatment centers in the US, valued at 15 MSEK. This is a specific business development announcement regarding a contract win, not a periodic financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). It details a significant transaction/contract. Since there is no specific category for 'Contract Win' or 'Business Update' that isn't financial results, and it is a formal announcement of a business event, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements that don't fit the highly specific financial or governance categories. Given the content is a specific business announcement, RNS is the most appropriate general regulatory filing category.
2020-12-28 English
C-RAD erhåller order till proton cancerkliniker i USA
Regulatory Filings Classification · 1% confidence The document is a press release dated 2020-12-28 announcing that C-RAD has received an order worth 15 MSEK for its surface scanning solutions for three proton therapy cancer centers in the USA. It details the technology involved (Catalyst PT, Sentinel 4DCT) and the expected delivery timeline. The final paragraph explicitly states: "Denna information är sådan information som C-RAD AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is information that C-RAD AB (publ) is obliged to disclose under the EU's Market Abuse Regulation). This structure—a formal announcement of a significant business event (a large order) mandated by market regulations—fits best under the general 'Regulatory Filings' category (RNS) as it is not a specific financial report (10-K, IR, ER), a management change (MANG), or a capital action (CAP/SHA). It is a general regulatory disclosure.
2020-12-28 Swedish
C-RAD har valts för att utrusta Shenzhens protoncancercenter i Kina med Catalyst ™ system
Regulatory Filings Classification · 1% confidence The document is a press release dated 2020-12-23 announcing that C-RAD has received a purchase order from IBA for its Catalyst™ and Sentinel™ systems for the Shenzhen proton therapy center in China. It details the order value (approx. 12 MSEK) and when it will be recognized as an order intake (Q4). The final paragraph explicitly states: "Denna information är sådan information som C-RAD AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is information that C-RAD AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation.) This structure—a brief announcement of a significant event or contract, often mandated by market regulations, rather than a full financial report (10-K, IR) or a transcript (CT)—points towards a general regulatory announcement. Since it is not a specific filing like DIRS, DIV, or CAP, and it is a formal disclosure required by market rules, the most appropriate general category is Regulatory Filings (RNS). It is too specific to be a generic LTR or too short/announcement-focused to be a full MDA or ER.
2020-12-23 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.